The case for evaluation of double mutant heat-labile toxin as an adjuvant to improve oral cholera vaccine immunogenicity.

Saved in:
Bibliographic Details
Title: The case for evaluation of double mutant heat-labile toxin as an adjuvant to improve oral cholera vaccine immunogenicity.
Authors: Bourgeois AL; Enteric Diseases Program, Naval Medical Research Institute (NMRI), Bethesda, MD, United States.; Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States., Scott DA; Enteric Diseases Program, Naval Medical Research Institute (NMRI), Bethesda, MD, United States., Baqar S; Enteric Diseases Program, Naval Medical Research Institute (NMRI), Bethesda, MD, United States.; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States., Tribble DR; Enteric Diseases Program, Naval Medical Research Institute (NMRI), Bethesda, MD, United States.; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, United States., Svennerholm AM; Department of Microbiology and Immunology, University of Gothenburg, Gothenburg, Sweden., Walker RI; Center for Vaccine Innovation and Access, PATH, Washington, DC, United States.
Source: Frontiers in immunology [Front Immunol] 2026 Apr 20; Vol. 17, pp. 1805998. Date of Electronic Publication: 2026 Apr 20 (Print Publication: 2026).
Publication Type: Clinical Trial; Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2026.1805998